CLINICAL_TRIALS
trial_result
· 2018-12-13
Clinical Trial Update: Dose Escalation Study for Primary Hepatocellular Carcinoma [NA]
Summary
A dose-escalation clinical trial for hepatocellular carcinoma has completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Indiana University School of Medicine | Conditions: Carcinoma, Hepatocellular | NA | Status: COMPLETED | Results posted: 2018-12-13